4 documents found

Accuracy of GynTect ® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3 : A Proof-of-Concept Case-Control…

aus: Cancers
Simple Summary Women treated for cervical precancers (CIN2/3) have an increased risk for recurrent lesions and therefore require post-treatment monitoring. Standard follow-up care based on hrHPV-DNA/cytology co-testing has high sensitivity but limited specificity. Host cell methylation correlates highly…
Basel: MDPI, 2024-08-30

Evaluation of CIN2/3 Lesion Regression in GynTect ® DNA Methylation-Marker-Negative Patients in a Longitudinal Study

aus: Cancers
Simple Summary Precancerous cervical lesions, especially among young women, are frequently cleared by the immune system. Consequently, immediate surgical treatment is not mandatory and patients are monitored closely for up to 24 months. To avoid anxiety and to allow for a more individualized treatment,…
Basel: MDPI, 2023-08-03

Association between antenatal glucocorticoid exposure and the activity of the stress system, cognition, and behavior in 8‐…

Introduction Glucocorticoid (GC) ‐induced fetal programming of the activity of the hypothalamus–pituitary–adrenal axis (HPAA) and its associated cognitive and behavioral consequences in later life have been well characterized in several animal species. However, information on humans is scarce. In this…
Malden, Massachusetts: Wiley-Blackwell, 2022-08-03

Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the…

The development of cervical cancer is frequently accompanied by the integration of human papillomaviruses (HPV) DNA into the host genome. Viral-cellular junction sequences, which arise in consequence, are highly tumor specific. By using these fragments as markers for tumor cell origin, we examined cervical…
Basel: Molecular Diversity Preservation International, 2017-09-22